Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Green Light for Generic Vizamyl Clinical Trial

December 3, 2024
CompanyMedical Device

Sansure Biotech’s HPV Detection Kit Receives NMPA Approval for Comprehensive Screening

October 24, 2024
CompanyDigital

ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment

October 24, 2024
CompanyDrug

Sino Biopharmaceutical Receives NMPA Approval for Rivastigmine Patch for Mild-to-Moderate Alzheimer’s

October 24, 2024
CompanyDeals

Belief BioMed Partners with Bayer’s AskBio to Explore New Gene Therapies

October 24, 2024
CompanyDeals

Shanghai Fosun Pharmaceutical Partners with State-owned Firms to Boost ASEAN Drug Trade

October 24, 2024
Policy / Regulatory

Beijing Authorities Launch Plan to Streamline Temporary Import of Urgently Needed Medical Drugs and Devices

October 25, 2024
HospitalPolicy / Regulatory

Beijing Expands Medical Insurance Coverage to Include Anti-Aquaporin Antibody Testing and Advanced Heart Procedures

October 25, 2024
CompanyDrug

Innovent Biologics Submits Market Approval Filing for Picankibart in Plaque Psoriasis to China’s CDE

October 25, 2024
CompanyDrug

Shanghai Haihe Pharmaceutical’s Oral Paclitaxel RMX3001 Wins NMPA Nod for Advanced Gastric Cancer

October 25, 2024
CompanyDeals

TJ Biopharma and Sanofi Ink Deal for Anti-CD73 Antibody Uliledlimab in Greater China

October 25, 2024
CompanyDeals

Sanofi’s Consumer Health Unit Attracts Binding Offers, Potential EUR 15 Billion Deal

November 23, 2024
1 2 3 4 5 6 … 24 25
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up